Cambridge, MA, United States of America

Mei Wei Chen

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Syros Pharmaceuticals, Inc.. Active years: 2017-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei Wei Chen. Retrieved from https://idiyas.com/inventor/mei-wei-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mei Wei Chen

Introduction: Mei Wei Chen is a pioneering inventor based in Cambridge, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Mei Wei Chen's recent patents focus on sustainable energy solutions and advanced medical devices, showcasing her versatility and forward-thinking approach.

Career Highlights: With a background in engineering and a passion for problem-solving, Mei Wei Chen has led numerous projects that have resulted in patented inventions that have positively impacted society.

Collaborations: Mei Wei Chen has collaborated with leading research institutions, universities, and companies to bring her innovative ideas to life, demonstrating her ability to work effectively in multidisciplinary teams.

Conclusion: Mei Wei Chen's dedication to innovation and her remarkable ability to turn ideas into tangible inventions make her a standout figure in the world of inventors. Her work continues to inspire and shape the future of technology and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…